Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
Fundamentals
Mkt Cap
$1.53B
Volume
-
52W High
$59.36
52W Low
$7.19
PE Ratio
-2.88
Avg. Volume
67,184.85
EPS (Annual)
-$7.76
P/B
4.05
Rev/Employee
$2,074,000.00
Earnings
-
59
Bullish Sentiment
How do you feel about CYCN?
ShadowSnake
$CYCN I had no clue the merger included a reverse split… glad I took the loss before this mess.. wow